Abstract
Approximately 39.6% of people will be diagnosed with cancer during their lifetime. Several factors including, lifestyle, environment and genetics may play a role in its development. Understanding these causes will greatly improve treatment methods, prevention, and survival rates of these patients. Our patient, who has a positive family history of cancer, presented with contralateral breast cancer and multiple skin malignancies. Genetic testing revealed a frameshift variant in NBN. This gene encodes the protein, nibrin, which is involved in maintaining genomic stability. Several reports have identified heterozygous NBN frameshift (c.2028delT, c.2097dupT, c.657-661delACAAA) and splice site variants (c.1397+delG) in patients with breast cancer. However, our report is the first to describe a heterozygous c.698_701delAACA NBN variant in a patient with breast cancer. Since NBN is involved in DNA integrity, loss of functional protein due to pathogenic variants significantly increases the risk of various cancers. Given the family and personal history of our patient, in connection with previous reports of NBN pathogenic variants predisposition to cancer, this variant is predicted to be pathogenic and clinically significant.
References
Apostolou P, Fostira F (2013) Hereditary breast cancer: the era of new susceptibility genes. BioMed Res Int 2013:747318
Hollestelle A, Wasielewski M, Martens JW et al (2010) Discovering moderate-risk breast cancer susceptibility genes. Curr Opin Genet Dev 20(3):268–276
Williams GJ, Lees-Miller SP, Tainer JA (2010) Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks. DNA Repair 9(12):1299–1306
Heikkinen K, Rapakko K, Karppinen SM et al (2006) RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27(8):1593–1599
Easton DF, Pharoah PD, Antoniou AC et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243–2257
Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E et al (2007) Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 157(Suppl 2):47–51
Zhang B, Beeghly-Fadiel A, Long J et al (2011) Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 12(5):477–488
Shiovitz S, Korde LA (2015) Genetics of breast cancer: a topic in evolution. Ann Oncol 26(7):1291–1299
Welcsh PL, King MC (2001) BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10(7):705–713
Varon R, Vissinga C, Platzer M et al (1998) Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93(3):467–476
Chrzanowska KH, Gregorek H, Dembowska-Baginska B et al (2012) Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis 7:13
di Masi A, Antoccia A (2008) NBS1 heterozygosity and cancer risk. Curr Genom 9(4):275–281
Berardinelli F, di Masi A, Antoccia A (2013) NBN gene polymorphisms and cancer susceptibility: a systemic review. Curr Genom 14(7):425–440
Kraus C, Hoyer J, Vasileiou G et al (2017) Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2. Int J Cancer 140(1):95–102
Ring KL, Bruegl AS, Allen BA et al (2016) Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. Mod Pathol 29(11):1381–1389
Tanzanella C, Antoccia A, Spadoni E et al (2003) Chromosome instability and nibrin protein variants in NBS heterozygotes. Eur J Hum Genet 11(4):297–303
Cilli D, Mirasole C, Pennisi R et al (2014) Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation. PLoS ONE 9(12):e114651
Mendez G, Cilli D, Berardinelli F et al (2012) Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation. IUBMB Life 64(10):853–861
Wessendorf P, Vijg J, Nussenzweig A et al (2014) Deficiency of the DNA repair protein nibrin increases the basal but not the radiation induced mutation frequency in vivo. Mutat Res 769:11–16
Dumon-Jones V, Frappart PO, Tong WM et al (2003) Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res 63(21):7263–7269
Ebi H, Matsuo K, Sugito N et al (2007) Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer. Cancer Res 67(23):11158–11165
Acknowledgements
The authors would like to thank the patient and family for their permission to publish this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors disclose no potential conflict of interest.
Rights and permissions
About this article
Cite this article
Gass, J., Jackson, J., Macklin, S. et al. A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA. Familial Cancer 16, 551–553 (2017). https://doi.org/10.1007/s10689-017-9982-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-017-9982-0